FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

De Novo OK for Google Phone Thermometer

FDA grants Google a de novo marketing authorization for its new body temperature app on its latest Pixel 8 Pro smart phone.

latest-news-card-1
Human Drugs

Postmarketing Drug Surveillance Best Practices

FDA releases a document entitled Best Practices for FDA Staff in the Postmarketing Safety Surveillance of Human Drug and Biological Products.

latest-news-card-1
Medical Devices

FDA Should Identify AI Legislative Changes: GAO

A new GAO reports recommends that FDA identify and document specific changes to its statutory authorities that would enable it to best oversee artific...

latest-news-card-1
Human Drugs

ICH Guide on Analytical Procedure Development

The International Council for Harmonization releases a guidance entitled Q14 Guideline on Analytical Procedure Development.

latest-news-card-1
Human Drugs

Remote Regulatory Assessments Draft Guide

FDA makes available a revised draft guidance entitled Conducting Remote Regulatory Assessments (RRA) Questions and Answers.

latest-news-card-1
Federal Register

Vaccines/Biologics Advisory Committee Renewal

Federal Register notice: FDA announces the renewal of its Vaccines and Related Biological Products Advisory Committee for an additional two years.

latest-news-card-1
Human Drugs

FDA Delays Review Action on Liquidia NDA

FDA tells Liquidia Corp. that its earlier user fee review action target date of 1/24 will be missed on the companys NDA for Yutrepia (treprostinil) in...

latest-news-card-1
Human Drugs

FDA Featured in 2024 Top-of-Mind Issues Report

A Sheppard Mullin report describes several FDA issues that life sciences companies can expect to face in 2024.

latest-news-card-1
Human Drugs

QMM Protocol Volunteers Sought

FDA says it is looking for nine drug establishments to volunteer to test CDERs new QMM prototype assessment protocol.

latest-news-card-1
Federal Register

Guide on Revising ANDA Labeling

Federal Register notice: FDA makes available a final guidance entitled Revising ANDA Labeling Following Revision of the RLD Labeling.